These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31479715)

  • 1. Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498.
    Wang Y; Li Y; He H; Wang F
    Gene; 2019 Dec; 720():144099. PubMed ID: 31479715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
    Pang J; Ye L; Zhao D; Zhao D; Chen Q
    Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
    Liu JQ; Feng YH; Zeng S; Zhong MZ
    Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
    Jiang Z; Yin J; Peng G; Long X
    Anticancer Drugs; 2021 Jan; 32(1):1-10. PubMed ID: 32932275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis.
    Li Y; Hu J; Li L; Cai S; Zhang H; Zhu X; Guan G; Dong X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):2089-2094. PubMed ID: 30103946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circ_0001649 acts as a prognostic biomarker and inhibits NSCLC progression via sponging miR-331-3p and miR-338-5p.
    Liu T; Song Z; Gai Y
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1503-1509. PubMed ID: 30029881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer.
    Yong W; Zhuoqi X; Baocheng W; Dongsheng Z; Chuan Z; Yueming S
    Biomed Pharmacother; 2018 Jun; 102():1188-1194. PubMed ID: 29710537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
    Wei D; Sun L; Feng W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ_0026134 regulates non-small cell lung cancer cell proliferation and invasion via sponging miR-1256 and miR-1287.
    Chang H; Qu J; Wang J; Liang X; Sun W
    Biomed Pharmacother; 2019 Apr; 112():108743. PubMed ID: 30970529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 14. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
    Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M
    J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.
    Bai Q; Li L; Chen F; Zhu J; Cao L; Yang Y; Zhong F
    Med Sci Monit; 2020 Jun; 26():e921200. PubMed ID: 32508344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer.
    Liu G; Shi H; Deng L; Zheng H; Kong W; Wen X; Bi H
    Biochem Biophys Res Commun; 2019 May; 513(1):207-212. PubMed ID: 30954221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
    Wan J; Hao L; Zheng X; Li Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.